Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Trump administration, pharma clash: 4 notes
Beckers Hospital Review
Monday, February 24, 2025 - 4:54pm
tags:
Donald Trump, tariffs, Eli Lilly, Merck, Pfizer, PhRMA
Pfizer names Patrizia Cavazzoni, former top FDA official, as chief medical officer
BioPharma Dive
Monday, February 24, 2025 - 4:52pm
tags:
Pfizer, FDA, Patrizia Cavazzoni
Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets
Fierce Biotech
Monday, February 24, 2025 - 11:32am
tags:
Sanofi, Teva Pharmaceutical, Merck, Roche, clinical trials, duvakitug, IBD, inflammatory bowel disease
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Fierce Biotech
Monday, February 24, 2025 - 11:30am
tags:
Medtronic, Medtech, FDA, neurostimulation, Parkinson's Disease, BrainSense
Following their flashy Super Bowl ad buys, healthcare and pharma players face pushback
Medical Marketing and Media
Monday, February 24, 2025 - 11:19am
tags:
pharma advertising, Super Bowl
VitalConnect raises $100M for heart monitor patch
Medtech Dive
Monday, February 24, 2025 - 11:17am
tags:
VitalConnect, Medtech, heart monitor patch, arrhythmia, Vitalpatch, funding
FDA Clears Entrada Therapeutics' Early-Stage For Potential Treatment Of Duchenne Muscular Dystrophy
Benzinga
Monday, February 24, 2025 - 11:15am
tags:
Entrada Therapeutics, ENTR-601-44, DMD, Duchenne Muscular Dystrophy, FDA
Pfizer inks deal to test Summit’s white-hot bispecific with ADCs
Fierce Biotech
Monday, February 24, 2025 - 11:11am
tags:
Pfizer, Summit Therapeutics, ivonescimab, antibody-drug conjugates
Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4
Fierce Pharma
Monday, February 24, 2025 - 11:09am
tags:
earnings, Big Pharma, Eli Lilly, Novo Nordisk
OSE’s UC therapy prompts 16% clinical remission after ten weeks
Clinical Trials Arena
Monday, February 24, 2025 - 10:17am
tags:
OSE Therapeutics, lusvertikimab, clinical trials, ulcerative colitis
Amgen plans $200M investment in India site
Tip Ranks
Monday, February 24, 2025 - 9:59am
tags:
Amgen, India
Kennedy’s MAHA agenda is tackling ‘conflicts of interest’ — and could take aim at FDA adcomms
Pharma Voice
Monday, February 24, 2025 - 9:57am
tags:
Robert F Kennedy Jr., HHS, FDA, drug approvals
FDA looks at Opdivo/Yervoy in first-line colorectal cancer
Pharmaphorum
Monday, February 24, 2025 - 9:56am
tags:
Bristol Myers Squibb, Opdivo, Yervoy, colorectal cancer, FDA, Keytruda, Merck
J&J’s fully subcutaneous Tremfya shows 27.6% clinical remission in UC
Clinical Trials Arena
Sunday, February 23, 2025 - 10:46pm
tags:
JNJ, Tremfya, ulcerative colitis, clinical trials
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Forbes
Sunday, February 23, 2025 - 10:44pm
tags:
vaccines, MRNA, pancreatic cancer
NIH funding freeze stalls applications on $1.5 billion in medical research funds
NPR
Sunday, February 23, 2025 - 10:42pm
tags:
R&D, NIH, Donald Trump
Deputy director of FDA's CBER departs amid mass exodus at federal health agencies
Fierce Biotech
Sunday, February 23, 2025 - 10:40pm
tags:
FDA, CBER, Donald Trump
FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol
Benzinga
Sunday, February 23, 2025 - 10:38pm
tags:
Mirum Pharmaceuticals, FDA, Ctexli, cerebrotendinous xanthomatosis
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
MSN/Reuters
Friday, February 21, 2025 - 11:18am
tags:
Teva Pharmaceutical, Alvotech, biosimilars, Stelara, autoimmune disease, Selarsdi, Crohn's Disease, ulcerative colitis, plaque psoriasis
AstraZeneca builds in China as Cosette buys Mayne
Pharmaphorum
Friday, February 21, 2025 - 11:09am
tags:
M&A, Cosette, Mayne Pharma, AstraZeneca, China, FibroGen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.